Chemoinformaics analysis of 1-Methyl-1-propylhydrazine
| Molecular Weight | 88.154 | nRot | 2 |
| Heavy Atom Molecular Weight | 76.058 | nRig | 0 |
| Exact Molecular Weight | 88.1001 | nRing | 0 |
| Solubility: LogS | 0.923 | nHRing | 0 |
| Solubility: LogP | 0.128 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.8815 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.386 |
| Synth | 2.875 |
| Natural Product Likeliness | -1.128 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.04 |
| HIA | 0.003 |
| CACO-2 | -4.647 |
| MDCK | 0.0000198 |
| BBB | 0.488 |
| PPB | 0.056406 |
| VDSS | 1.324 |
| FU | 0.886113 |
| CYP1A2-inh | 0.122 |
| CYP1A2-sub | 0.387 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.902 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.148 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.869 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.215 |
| CL | 8.351 |
| T12 | 0.617 |
| hERG | 0.024 |
| Ames | 0.124 |
| ROA | 0.947 |
| SkinSen | 0.758 |
| Carcinogencity | 0.956 |
| EI | 0.804 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.959727 |